Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Altimmune Inc (ALT)

Altimmune Inc (ALT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Altimmune Inc 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 USA

P: 240-654-1450

Description:

Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly known as Pharmathene Inc., is based in Gaithersburg, United States.

Key Statistics

Overview:

Market Capitalization, $K 209,612
Shares Outstanding, K 43,219
Annual Sales, $ 4,410 K
Annual Net Income, $ -97,090 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -19,430 K
60-Month Beta 1.45
% of Insider Shareholders 3.14%
% of Institutional Shareholders 88.00%
Float, K 41,862
% Float 96.86%
Short Volume Ratio 0.59

Growth:

1-Year Return -60.59%
3-Year Return 94.24%
5-Year Return -96.32%
5-Year Revenue Growth -15.68%
5-Year Earnings Growth -100.23%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.44 on 05/12/22
Next Earnings Date N/A
Earnings Per Share ttm -2.14
EPS Growth vs. Prev Qtr 10.20%
EPS Growth vs. Prev Year -15.79%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 2.910 on 02/06/17
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 09/14/18

ALT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -43.27%
Return-on-Assets % -39.31%
Profit Margin % -2,201.59
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 49.20
Price/Cash Flow N/A
Price/Book 1.13
Book Value/Share 4.28
Interest Coverage -9,708.00

ALT Dividends

Date Value
02/06/17 $2.9100
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar